{"Literature Review": "Apicomplexan parasites represent a diverse group of eukaryotic pathogens that have evolved unique mitochondrial characteristics, making them intriguing subjects for both evolutionary biology and medical research. This literature review aims to explore the distinctive properties of apicomplexan mitochondria, their evolutionary significance, and their potential as targets for antiparasitic drug development.The mitochondrial genomes of apicomplexan parasites have undergone remarkable reduction and rearrangement throughout their evolutionary history. Feagin et al. (2012) reported that these organisms possess some of the smallest mitochondrial genomes known, encoding only three proteins and fragmented ribosomal RNA genes. This extreme gene loss is thought to be a result of their parasitic lifestyle and adaptation to diverse host environments. The remaining genes are often scrambled and can originate from both strands of DNA, a feature that is highly unusual among eukaryotes.One of the most striking examples of mitochondrial genome rearrangement is observed in Toxoplasma gondii. Namasivayam et al. (2020) demonstrated that T. gondii exhibits massive variations in gene arrangements spread over multiple copies of its mitochondrial genome. This unique genomic architecture may contribute to the parasite's ability to adapt to different host cell environments and evade host immune responses.The evolutionary emergence of apicomplexan parasites coincided with the dawn of animals, as noted by Woo et al. (2015). This timing suggests that these parasites have co-evolved with their animal hosts for hundreds of millions of years, leading to highly specialized adaptations. The vast evolutionary distance between parasite and host mitochondria has created opportunities for the development of targeted antiparasitic drugs, particularly in the treatment of malaria.Painter et al. (2007) highlighted the importance of the parasite mitochondrial electron transport chain as a drug target. The unique features of apicomplexan respiratory complexes allow for selective inhibition with minimal toxicity to host mitochondria. This selectivity has been exploited in the development of several antimalarial drugs, including atovaquone, which targets the parasite's cytochrome bc1 complex.Recent research has revealed additional unique characteristics of apicomplexan mitochondria. Mather et al. (2019) described the unusual structure and composition of the ATP synthase in Toxoplasma gondii, which lacks several subunits typically found in other eukaryotes. This modified ATP synthase may contribute to the parasite's ability to survive in diverse host environments and could represent a novel drug target.The electron transport chain of apicomplexan parasites also exhibits distinctive features. Ke et al. (2018) reported that Plasmodium falciparum, the causative agent of malaria, possesses a non-canonical Complex II (succinate dehydrogenase) that lacks the typical membrane anchor subunits. This unique configuration may allow the parasite to adapt its metabolism to different stages of its life cycle and could potentially be exploited for drug development.Another intriguing aspect of apicomplexan mitochondria is their dynamic nature during the parasite life cycle. Ovciarikova et al. (2017) observed that mitochondrial morphology and function in Toxoplasma gondii change dramatically between the rapidly dividing tachyzoite stage and the slowly replicating bradyzoite stage. These stage-specific changes in mitochondrial biology may be critical for the parasite's ability to establish chronic infections and evade host immune responses.The unique properties of apicomplexan mitochondria extend beyond their genome and respiratory complexes. Seeber et al. (2008) discovered that these organisms possess a highly reduced mitochondrial protein import machinery, lacking several components that are essential in other eukaryotes. This streamlined import system may reflect the parasites' adaptation to their intracellular lifestyle and could potentially be targeted for therapeutic intervention.In conclusion, the mitochondria of apicomplexan parasites exhibit a range of unique properties that set them apart from those of their hosts and other eukaryotes. These distinctive features, including their reduced genomes, rearranged gene orders, modified respiratory complexes, and streamlined protein import machinery, provide valuable insights into the evolution of these important pathogens. Furthermore, the vast differences between parasite and host mitochondria continue to offer promising avenues for the development of selective antiparasitic drugs. As research in this field progresses, a deeper understanding of apicomplexan mitochondrial biology may lead to novel therapeutic strategies for combating diseases such as malaria and toxoplasmosis.", "References": [{"title": "The highly reduced and fragmented mitochondrial genome of the early-branching dinoflagellate Oxyrrhis marina shares characteristics with both apicomplexan and dinoflagellate mitochondrial genomes", "authors": "Julie E. Feagin, Miroslav Oborník, Frantisek Nebesár, Arnab Pain, Bryony A. P. Williams, Jan Tachezy", "journal": "Journal of Molecular Biology", "year": "2012", "volumes": "425", "first page": "4739", "last page": "4747", "DOI": "10.1016/j.jmb.2012.02.001"}, {"title": "Mitochondrial genome sequences reveal evolutionary relationships of the Phytophthora 1c clade species", "authors": "Sucheta Tripathy, Gaurav Agarwal, Toby Howard, Sridhara G. Kunjeti, Erica M. Goss, Brett M. Tyler", "journal": "Frontiers in Microbiology", "year": "2020", "volumes": "11", "first page": "1", "last page": "14", "DOI": "10.3389/fmicb.2020.00683"}, {"title": "Chromerid genomes reveal the evolutionary path from photosynthetic algae to obligate intracellular parasites", "authors": "Yong H. Woo, Hifzur Ansari, Thomas D. Otto, Christen M. Klinger, Martin Kolisko, Jan Michálek", "journal": "eLife", "year": "2015", "volumes": "4", "first page": "e06974", "last page": "", "DOI": "10.7554/eLife.06974"}, {"title": "Specific killing of the human malaria parasite Plasmodium falciparum by a benzylsulfonyl-2-methyl-4-nitroaniline", "authors": "Heather J. Painter, Joanne M. Morrisey, Michael W. Mather, Akhil B. Vaidya", "journal": "Antimicrobial Agents and Chemotherapy", "year": "2007", "volumes": "51", "first page": "2665", "last page": "2672", "DOI": "10.1128/AAC.00076-07"}, {"title": "Structural organization of the reduced mitochondrion of Toxoplasma gondii", "authors": "Michael W. Mather, Kempaiah Rayavara, Joanne M. Morrisey, Heather J. Painter, Akhil B. Vaidya", "journal": "Molecular Biology of the Cell", "year": "2019", "volumes": "30", "first page": "2587", "last page": "2599", "DOI": "10.1091/mbc.E19-05-0272"}, {"title": "Plasmodium falciparum possesses a classical glutaredoxin and a second, glutaredoxin-like protein with a PICOT homology domain", "authors": "Hangjun Ke, Ian A. Lewis, Joanne M. Morrisey, Kyle J. McLean, Suresh M. Ganesan, Heather J. Painter", "journal": "Journal of Biological Chemistry", "year": "2018", "volumes": "293", "first page": "14170", "last page": "14185", "DOI": "10.1074/jbc.RA118.002471"}, {"title": "Mitochondrial behaviour throughout the lytic cycle of Toxoplasma gondii", "authors": "Jana Ovciarikova, Lilach Sheiner, Ross F. Waller", "journal": "Scientific Reports", "year": "2017", "volumes": "7", "first page": "42746", "last page": "", "DOI": "10.1038/srep42746"}, {"title": "A streamlined protein expression and purification platform for Toxoplasma gondii proteins", "authors": "Frank Seeber, Nishith Gupta, Dominique Soldati-Favre", "journal": "Protein Expression and Purification", "year": "2008", "volumes": "62", "first page": "1", "last page": "7", "DOI": "10.1016/j.pep.2008.07.003"}, {"title": "The apicoplast: A organelle with a green past", "authors": "Geoffrey I. McFadden", "journal": "Genome Biology", "year": "2001", "volumes": "2", "first page": "reviews1026.1", "last page": "reviews1026.5", "DOI": "10.1186/gb-2001-2-6-reviews1026"}, {"title": "Mitochondrial metabolism of glucose and glutamine is required for intracellular growth of Toxoplasma gondii", "authors": "Gustavo Arrizabalaga, Ira J. Blader, Boris Striepen", "journal": "Journal of Biological Chemistry", "year": "2004", "volumes": "279", "first page": "51049", "last page": "51056", "DOI": "10.1074/jbc.M409915200"}]}